Roche’s Virtual Event following ASH 2020 Webcast Replay
Agenda:
Welcome
Hematology Franchise Overview
Review of Key Clinical Data Presented at ASH
Q&A
Karl Mahler, Head of Investor Relations and Roche Group Planning
Thomas Fuchs, Vice President, Hematology Franchise Head, Global Product Strategy
Ginna Laport, Vice President & Global Head of Hematology NHL/CLL
Marion Ott, M.D., PhD - Global Franchise Head AML, Multiple Myeloma and Pediatric Development